Delve into our extensive collection of clinically published studies showcasing real-world evidence.
Viz™ LVO
In a multi-center cluster randomized trial, implementation of an automated LVO detection algorithm improved treatment times [median DTG] in patients...
Feb 02, 2023
Viz™ LVO
There was a prominent reduction in CTA performed in the United States due to contrast media shortage. However, the proportion...
Feb 02, 2023
Viz™ LVO
Comparison of scores for identifying patients with vertebrobasilar occlusions who may benefit from EVT. CLEOS can predict risk of poor...
Jan 09, 2023
Viz™ ANEURYSM
Background Unruptured cerebral aneurysms (UCAs) have a relatively low prevalence of approximately 3%, but detection can prevent devastating consequences of...
Nov 16, 2022
Viz™ SUBDURAL
Background Machine learning algorithms have shown groundbreaking results in neuroimaging. Herein, the authors evaluate the performance of a newly developed...
Sep 30, 2022
Viz™ LVO
Background The Viz.ai artificial intelligence (AI) software module Viz large‐vessel occlusion (LVO) utilizes AI‐powered LVO detection and triage technology to...
Sep 07, 2022
Viz™ CTP
Background Treatment of acute ischemic stroke with large‐vessel occlusion in the late windows expanded dramatically with the positive results of...
Jul 05, 2022
Viz™ CTP
Background We aimed to compare the perfusion parametric maps and the determination of predicted ischemic core between three automated CT...
May 11, 2022
Viz™ LVO
Background Comprehensive Stroke Centers (CSCs) strive to narrow rt-PA and “Door To Groin” (DTG) neurointerventional (NIR) times. Process improvement workflows...
Feb 03, 2022
